Transcriptome dynamics of transgene amplification in Chinese hamster ovary cells

Dihydrofolate reductase (DHFR) system is used to amplify the product gene to multiple copies in Chinese Hamster Ovary (CHO) cells for generating cell lines which produce the recombinant protein at high levels. The physiological changes accompanying the transformation of the non‐protein secreting host cells to a high producing cell line is not well characterized. We performed transcriptome analysis on CHO cells undergoing the selection and amplification processes. A host CHO cell line was transfected with a vector containing genes encoding the mouse DHFR (mDHFR) and a recombinant human IgG (hIgG). Clones were isolated following selection and subcloned following amplification. Control cells were transfected with a control plasmid which did not have the hIgG genes. Although methotrexate (MTX) amplification increased the transcript level of the mDHFR gene significantly, its effect on both hIgG heavy and light chain genes was more modest. The subclones appeared to retain the transcriptome signatures of their parental clones, however, their productivity varied among those derived from the same clone. The transcript levels of hIgG transgenes of all subclones fall in a narrower range than the product titer, alluding to the role of many functional attributes, other than transgene transcript, on productivity. We cross examined functional class enrichment during selection and amplification as well as between high and low producers and discerned common features among them. We hypothesize that the role of amplification is not merely increasing transcript levels, but also enriching survivors which have developed the cellular machinery for secreting proteins, leading to an increased frequency of isolating high‐producing clones. We put forward the possibility of assembling a hyper‐productivity gene set through comparative transcriptome analysis of a wide range of samples. Biotechnol. Bioeng. 2014;111: 518–528. © 2013 Wiley Periodicals, Inc.

[1]  P. Sharp,et al.  Evolution of chromosomal regions containing transfected and amplified dihydrofolate reductase sequences , 1983, Molecular and cellular biology.

[2]  Gregory H Underhill,et al.  Gene expression profiling reveals a highly specialized genetic program of plasma cells. , 2003, Blood.

[3]  W. White,et al.  Methotrexate-resistant Chinese hamster ovary cells have amplified a 135-kilobase-pair region that includes the dihydrofolate reductase gene. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Racher,et al.  On the Optimal Ratio of Heavy to Light Chain Genes for Efficient Recombinant Antibody Production by CHO Cells , 2008, Biotechnology progress.

[5]  Wei-Shou Hu,et al.  Genomic and proteomic exploration of CHO and hybridoma cells under sodium butyrate treatment , 2008, Biotechnology and bioengineering.

[6]  Andrew J Racher,et al.  An empirical modeling platform to evaluate the relative control discrete CHO cell synthetic processes exert over recombinant monoclonal antibody production process titer , 2011, Biotechnology and bioengineering.

[7]  Andrew J Racher,et al.  Cell line‐specific control of recombinant monoclonal antibody production by CHO cells , 2010, Biotechnology and bioengineering.

[8]  Gyun Min Lee,et al.  CHO cells in biotechnology for production of recombinant proteins: current state and further potential , 2012, Applied Microbiology and Biotechnology.

[9]  Wei-Shou Hu,et al.  Comparative transcriptome analysis to unveil genes affecting recombinant protein productivity in mammalian cells , 2009, Biotechnology and bioengineering.

[10]  F. Wurm Production of recombinant protein therapeutics in cultivated mammalian cells , 2004, Nature Biotechnology.

[11]  G. M. Lee,et al.  Clonal variability within dihydrofolate reductase-mediated gene amplified Chinese hamster ovary cells: stability in the absence of selective pressure. , 1998, Biotechnology and bioengineering.

[12]  Salim Charaniya,et al.  In pursuit of a super producer-alternative paths to high producing recombinant mammalian cells. , 2007, Current opinion in biotechnology.

[13]  S. Dübel,et al.  Analysis of IgG heavy chain to light chain ratio with mutant Encephalomyocarditis virus internal ribosome entry site. , 2007, Protein engineering, design & selection : PEDS.

[14]  Niki S. C. Wong,et al.  A study of monoclonal antibody‐producing CHO cell lines: What makes a stable high producer? , 2009, Biotechnology and bioengineering.

[15]  G. Lee,et al.  Selection strategies for the establishment of recombinant Chinese hamster ovary cell line with dihydrofolate reductase-mediated gene amplification , 2005, Applied Microbiology and Biotechnology.

[16]  C. Ryu,et al.  Characterization of chimeric antibody producing CHO cells in the course of dihydrofolate reductase-mediated gene amplification and their stability in the absence of selective pressure. , 1998, Biotechnology and bioengineering.

[17]  S. Latt,et al.  Coamplification and coexpression of human tissue-type plasminogen activator and murine dihydrofolate reductase sequences in Chinese hamster ovary cells , 1985, Molecular and cellular biology.

[18]  R. Philp,et al.  Transcriptome and proteome profiling to understanding the biology of high productivity CHO cells , 2006, Molecular biotechnology.

[19]  L. Chasin,et al.  Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[21]  G. Lee,et al.  Key Determinants in the Occurrence of Clonal Variation in Humanized Antibody Expression of CHO Cells during Dihydrofolate Reductase Mediated Gene Amplification , 2001, Biotechnology progress.

[22]  C. Clarke,et al.  Transcriptomic analysis of clonal growth rate variation during CHO cell line development. , 2013, Journal of biotechnology.

[23]  M. Flickinger,et al.  A structured model for monoclonal antibody synthesis in exponentially growing and stationary phase hybridoma cells , 1991, Biotechnology and bioengineering.

[24]  Wei-Shou Hu,et al.  Transcriptome and proteome analysis of Chinese hamster ovary cells under low temperature and butyrate treatment. , 2010, Journal of biotechnology.

[25]  G. M. Lee,et al.  Cytogenetic analysis of chimeric antibody-producing CHO cells in the course of dihydrofolate reductase-mediated gene amplification and their stability in the absence of selective pressure. , 1999, Biotechnology and bioengineering.

[26]  Jason Dean,et al.  Metabolic analysis of antibody producing CHO cells in fed‐batch production , 2013, Biotechnology and bioengineering.

[27]  Katie F Wlaschin,et al.  Recombinant protein therapeutics from CHO cells : 20 years and counting , 2007 .

[28]  J. Fujii,et al.  B- to plasma-cell terminal differentiation entails oxidative stress and profound reshaping of the antioxidant responses. , 2010, Antioxidants & redox signaling.

[29]  J. Bailey,et al.  Effect of cloned gene dosage on cell growth and hepatitis B surface antigen synthesis and secretion in recombinant CHO cells , 1992, Biotechnology and bioengineering.

[30]  Wei-Shou Hu,et al.  Molecular portrait of high productivity in recombinant NS0 cells , 2007, Biotechnology and bioengineering.

[31]  J. Piret,et al.  Limitations to the amplification and stability of human tissue-type plasminogen activator expression by Chinese hamster ovary cells. , 2000, Biotechnology and bioengineering.

[32]  G. Karypis,et al.  Mining transcriptome data for function–trait relationship of hyper productivity of recombinant antibody , 2009, Biotechnology and bioengineering.

[33]  H. Katinger,et al.  Analysis of alterations in gene expression after amplification of recombinant genes in CHO cells. , 2001, Journal of biotechnology.

[34]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Flickinger,et al.  Evidence for posttranscriptional stimulation of monoclonal antibody secretion by L-glutamine during slow hybridoma growth. , 1992, Journal of biotechnology.

[36]  O. Merten,et al.  Kinetic studies of cellular metabolic activity, specific IgG production rate, IgG mRNA stability and accumulation during hybridoma batch culture. , 1992, Enzyme and microbial technology.

[37]  R. Sitia,et al.  Redox remodeling allows and controls B-cell activation and differentiation. , 2010, Antioxidants & redox signaling.